GB0022216D0 - Human FAP-a-specific antibodies for use in cancer therapy - Google Patents

Human FAP-a-specific antibodies for use in cancer therapy

Info

Publication number
GB0022216D0
GB0022216D0 GB0022216A GB0022216A GB0022216D0 GB 0022216 D0 GB0022216 D0 GB 0022216D0 GB 0022216 A GB0022216 A GB 0022216A GB 0022216 A GB0022216 A GB 0022216A GB 0022216 D0 GB0022216 D0 GB 0022216D0
Authority
GB
United Kingdom
Prior art keywords
specific antibodies
cancer therapy
human fap
fap
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0022216A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Priority to GB0022216A priority Critical patent/GB0022216D0/en
Publication of GB0022216D0 publication Critical patent/GB0022216D0/en
Priority to AU2001256325A priority patent/AU2001256325A1/en
Priority to JP2001567798A priority patent/JP2003530092A/en
Priority to EP01929604A priority patent/EP1268550A2/en
Priority to PCT/EP2001/004716 priority patent/WO2001068708A2/en
Priority to CA002401252A priority patent/CA2401252A1/en
Priority to US09/811,737 priority patent/US20020099180A1/en
Ceased legal-status Critical Current

Links

GB0022216A 2000-03-17 2000-09-11 Human FAP-a-specific antibodies for use in cancer therapy Ceased GB0022216D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0022216A GB0022216D0 (en) 2000-09-11 2000-09-11 Human FAP-a-specific antibodies for use in cancer therapy
AU2001256325A AU2001256325A1 (en) 2000-03-17 2001-03-16 Human and humanized fap-alpha-specific antibodies
JP2001567798A JP2003530092A (en) 2000-03-17 2001-03-16 Human FAP-α-specific antibody
EP01929604A EP1268550A2 (en) 2000-03-17 2001-03-16 Human fap-alpha-specific antibodies
PCT/EP2001/004716 WO2001068708A2 (en) 2000-03-17 2001-03-16 Human and humanized fap-alpha-specific antibodies
CA002401252A CA2401252A1 (en) 2000-03-17 2001-03-16 Human and humanized fap-alpha-specific antibodies
US09/811,737 US20020099180A1 (en) 2000-03-17 2001-03-19 Human FAP-alpha-specific antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0022216A GB0022216D0 (en) 2000-09-11 2000-09-11 Human FAP-a-specific antibodies for use in cancer therapy

Publications (1)

Publication Number Publication Date
GB0022216D0 true GB0022216D0 (en) 2000-10-25

Family

ID=9899200

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0022216A Ceased GB0022216D0 (en) 2000-03-17 2000-09-11 Human FAP-a-specific antibodies for use in cancer therapy

Country Status (1)

Country Link
GB (1) GB0022216D0 (en)

Similar Documents

Publication Publication Date Title
GB2386120B (en) Differentiated cells suitable for human therapy
LT2940044T (en) Anti-tnf alpha antibodies for use in therapy
EP1311262A4 (en) Cancer treatment by combination therapy
EE04528B1 (en) Aralam laminates for use in therapy for spirofurop ridins
GB0016787D0 (en) Compounds useful in therapy
IL157993A0 (en) Molecular conjugates for use in cancer treatment and methods for the preparation thereof
HUP0300005A3 (en) Modified cytokines for use in cancer therapy
IL156690A0 (en) Specific human antibodies for selective cancer therapy
HUP0300339A3 (en) Use of fulvestrant in the treatment of resistant breast cancer
GB0005257D0 (en) Breast cancer hormonal therapy
EP1385879A4 (en) Reproductive cancer diagnosis and therapy
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
GB0026015D0 (en) Cancer treatment
GB0022216D0 (en) Human FAP-a-specific antibodies for use in cancer therapy
GB2374018B (en) Ultrasound therapy
GB9906130D0 (en) Compounds for use in therapy
GB0014046D0 (en) Compounds useful in therapy
SI1157041T1 (en) Antibodies for cancer therapy and diagnosis
SI1251850T1 (en) Use of a combination preparation in cancer therapy
GB0130733D0 (en) Therapeutic compounds and their use in therapy
GB0015676D0 (en) Aryl compounds their preparation and their use in therapy
GB0024673D0 (en) Therapeutic antibodies
GB0030058D0 (en) Use of compounds in therapy
GB0017625D0 (en) Use of compounds in therapy
GB0012945D0 (en) Use of compounds in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)